Immunological and immunogenetic markers in sporadic Alzheimer's disease

Giuseppina Candore; Calogero Caruso; Domenico Lio; Letizia Scola; Giuseppina Colonna Romano

Immunological and immunogenetic markers in sporadic Alzheimer's disease

Giuseppina Candore, Calogero Caruso, Domenico Lio, Letizia Scola, Giuseppina Colonna Romano

Biomedicina, Neuroscienze e Diagnostica avanzata

Risultato della ricerca: Article › peer review

11 Citazioni (Scopus)

Abstract

Background: Common polymorphisms of genes controlling inflammation-modulating cytokines and acute-phase proteins which play important roles in the pathogenesis of Alzheimer''s disease (AD) have been shown to be associated with AD. Aims: The immunological and immunogenetic markers potentially useful for the AD risk evaluation and diagnosis are briefly reviewed. Conclusion: The state-of-the-art of immunological and immunogenetic markers of AD indicates that new tools and strategies are necessary to identify gene products useful as diagnostic tools.

Lingua originale	English
pagine (da-a)	163-166
Numero di pagine	4
Rivista	Aging clinical and experimental research
Volume	18
Stato di pubblicazione	Published - 2006

All Science Journal Classification (ASJC) codes

Ageing
Geriatrics and Gerontology

Altri file e collegamenti

OA Link

Fingerprint Entra nei temi di ricerca di 'Immunological and immunogenetic markers in sporadic Alzheimer's disease'. Insieme formano una fingerprint unica.

Cita questo

@article{4421ec0161f649ad95c0fe582e3435f1,

title = "Immunological and immunogenetic markers in sporadic Alzheimer's disease",

abstract = "Background: Common polymorphisms of genes controlling inflammation-modulating cytokines and acute-phase proteins which play important roles in the pathogenesis of Alzheimer''s disease (AD) have been shown to be associated with AD. Aims: The immunological and immunogenetic markers potentially useful for the AD risk evaluation and diagnosis are briefly reviewed. Conclusion: The state-of-the-art of immunological and immunogenetic markers of AD indicates that new tools and strategies are necessary to identify gene products useful as diagnostic tools.",

keywords = "Alzheimer{\textquoteright}s disease, cytokines, immunogenetics, inflammation, proteomics, Alzheimer{\textquoteright}s disease, cytokines, immunogenetics, inflammation, proteomics",

author = "Giuseppina Candore and Calogero Caruso and Domenico Lio and Letizia Scola and {Colonna Romano}, Giuseppina",

year = "2006",

language = "English",

volume = "18",

pages = "163--166",

journal = "Aging clinical and experimental research",

issn = "1594-0667",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Immunological and immunogenetic markers in sporadic Alzheimer's disease

AU - Candore, Giuseppina

AU - Caruso, Calogero

AU - Lio, Domenico

AU - Scola, Letizia

AU - Colonna Romano, Giuseppina

PY - 2006

Y1 - 2006

N2 - Background: Common polymorphisms of genes controlling inflammation-modulating cytokines and acute-phase proteins which play important roles in the pathogenesis of Alzheimer''s disease (AD) have been shown to be associated with AD. Aims: The immunological and immunogenetic markers potentially useful for the AD risk evaluation and diagnosis are briefly reviewed. Conclusion: The state-of-the-art of immunological and immunogenetic markers of AD indicates that new tools and strategies are necessary to identify gene products useful as diagnostic tools.

AB - Background: Common polymorphisms of genes controlling inflammation-modulating cytokines and acute-phase proteins which play important roles in the pathogenesis of Alzheimer''s disease (AD) have been shown to be associated with AD. Aims: The immunological and immunogenetic markers potentially useful for the AD risk evaluation and diagnosis are briefly reviewed. Conclusion: The state-of-the-art of immunological and immunogenetic markers of AD indicates that new tools and strategies are necessary to identify gene products useful as diagnostic tools.

KW - Alzheimer’s disease

KW - cytokines

KW - immunogenetics

KW - inflammation

KW - proteomics

KW - Alzheimer’s disease

KW - cytokines

KW - immunogenetics

KW - inflammation

KW - proteomics

UR - http://hdl.handle.net/10447/17627

M3 - Article

VL - 18

SP - 163

EP - 166

JO - Aging clinical and experimental research

JF - Aging clinical and experimental research

SN - 1594-0667

ER -